サマリー

消化管間質腫瘍治療薬の世界市場 2024-2028
消化管間質腫瘍治療薬市場は2023-2028年に10億2000万米ドルの成長が予測され、予測期間中のCAGRは6.01%で加速すると予測されます。当レポートでは、消化管間質腫瘍治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、老年人口の増加、ジスト治療薬の採用拡大、ジストに関する啓蒙活動の活発化などが牽引しています。
Technavio社の消化管間質腫瘍治療薬市場は以下のように区分されています：
流通チャネル別
- 病院薬局
- 小売薬局
- オンライン薬局
投与経路別
- 経口
- 非経口
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、今後数年間の消化管間質腫瘍治療薬市場の成長を促進する主な理由の1つとして、ジストの再生療法の登場を挙げています。また、ジスト治療薬の強力なパイプラインとジスト治療薬の研究資金の増加は、市場の大きな需要につながります。
この調査レポートは、消化管間質腫瘍治療薬市場を調査・分析し、以下の刊行物を出版しています：
- 消化管間質腫瘍治療薬市場のサイジング
- 消化管間質腫瘍治療薬市場予測
- 消化管間質腫瘍治療薬市場産業分析
堅牢なベンダー分析は、顧客が市場での地位を向上させるのに役立つように設計されており、これに伴い、本レポートでは、Ascentage Pharma社、Bayer AG社、Blueprint Medicines Corp、Bristol Myers Squibb Co.、Deciphera Pharmaceuticals Inc.、Mendus AB、Novartis AG、Pfizer Inc.、Sun Pharmaceutical Industries Ltd.、Xencor Inc.、AB Science SA、AROG Pharmaceuticals INC.、Ipsen Pharma、Theseus Pharmaceuticals、Daiichi Sankyo Co.Ltd.、Merck KGaA、武田薬品工業株式会社。また、消化管内視鏡検査は、消化管内視鏡検査と同様に、消化管内視鏡検査と同時に行われる。また、消化管間質腫瘍治療薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/gastrointestinal-stromal-tumors-therapeutics-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global gastrointestinal stromal tumors therapeutics market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global gastrointestinal stromal tumors therapeutics market 2018 - 2022 ($ billion)
o 4.2 Distribution Channel Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
o 4.3 Route of Administration Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Hospital pharmacies - Market size and forecast 2023-2028
o Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
o 6.4 Retail pharmacies - Market size and forecast 2023-2028
o Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
o 6.5 Online pharmacies - Market size and forecast 2023-2028
o Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ billion)
o Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)
• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 48: Chart on Route of Administration - Market share 2023-2028 (%)
o Exhibit 49: Data Table on Route of Administration - Market share 2023-2028 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 50: Chart on Comparison by Route of Administration
o Exhibit 51: Data Table on Comparison by Route of Administration
o 7.3 Oral - Market size and forecast 2023-2028
o Exhibit 52: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Oral - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Oral - Year-over-year growth 2023-2028 (%)
o 7.4 Parenteral - Market size and forecast 2023-2028
o Exhibit 56: Chart on Parenteral - Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Parenteral - Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Parenteral - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Route of Administration
o Exhibit 60: Market opportunity by Route of Administration ($ billion)
o Exhibit 61: Data Table on Market opportunity by Route of Administration ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 UK - Market size and forecast 2023-2028
o Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.9 China - Market size and forecast 2023-2028
o Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.10 France - Market size and forecast 2023-2028
o Exhibit 95: Chart on France - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on France - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on France - Year-over-year growth 2023-2028 (%)
o 9.11 Japan - Market size and forecast 2023-2028
o Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 AB Science SA
o Exhibit 111: AB Science SA - Overview
o Exhibit 112: AB Science SA - Product / Service
o Exhibit 113: AB Science SA - Key offerings
o 12.4 AROG Pharmaceuticals INC.
o Exhibit 114: AROG Pharmaceuticals INC. - Overview
o Exhibit 115: AROG Pharmaceuticals INC. - Product / Service
o Exhibit 116: AROG Pharmaceuticals INC. - Key offerings
o 12.5 Ascentage Pharma
o Exhibit 117: Ascentage Pharma - Overview
o Exhibit 118: Ascentage Pharma - Product / Service
o Exhibit 119: Ascentage Pharma - Key offerings
o 12.6 Bayer AG
o Exhibit 120: Bayer AG - Overview
o Exhibit 121: Bayer AG - Business segments
o Exhibit 122: Bayer AG - Key news
o Exhibit 123: Bayer AG - Key offerings
o Exhibit 124: Bayer AG - Segment focus
o 12.7 Blueprint Medicines Corp.
o Exhibit 125: Blueprint Medicines Corp. - Overview
o Exhibit 126: Blueprint Medicines Corp. - Product / Service
o Exhibit 127: Blueprint Medicines Corp. - Key news
o Exhibit 128: Blueprint Medicines Corp. - Key offerings
o 12.8 Bristol Myers Squibb Co.
o Exhibit 129: Bristol Myers Squibb Co. - Overview
o Exhibit 130: Bristol Myers Squibb Co. - Product / Service
o Exhibit 131: Bristol Myers Squibb Co. - Key news
o Exhibit 132: Bristol Myers Squibb Co. - Key offerings
o 12.9 Daiichi Sankyo Co. Ltd.
o Exhibit 133: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 134: Daiichi Sankyo Co. Ltd. - Product / Service
o Exhibit 135: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 136: Daiichi Sankyo Co. Ltd. - Key offerings
o 12.10 Deciphera Pharmaceuticals Inc
o Exhibit 137: Deciphera Pharmaceuticals Inc - Overview
o Exhibit 138: Deciphera Pharmaceuticals Inc - Business segments
o Exhibit 139: Deciphera Pharmaceuticals Inc - Key news
o Exhibit 140: Deciphera Pharmaceuticals Inc - Key offerings
o Exhibit 141: Deciphera Pharmaceuticals Inc - Segment focus
o 12.11 Ipsen Pharma
o Exhibit 142: Ipsen Pharma - Overview
o Exhibit 143: Ipsen Pharma - Business segments
o Exhibit 144: Ipsen Pharma - Key offerings
o Exhibit 145: Ipsen Pharma - Segment focus
o 12.12 Mendus AB
o Exhibit 146: Mendus AB - Overview
o Exhibit 147: Mendus AB - Product / Service
o Exhibit 148: Mendus AB - Key offerings
o 12.13 Novartis AG
o Exhibit 149: Novartis AG - Overview
o Exhibit 150: Novartis AG - Business segments
o Exhibit 151: Novartis AG - Key offerings
o Exhibit 152: Novartis AG - Segment focus
o 12.14 Pfizer Inc.
o Exhibit 153: Pfizer Inc. - Overview
o Exhibit 154: Pfizer Inc. - Product / Service
o Exhibit 155: Pfizer Inc. - Key news
o Exhibit 156: Pfizer Inc. - Key offerings
o 12.15 Sun Pharmaceutical Industries Ltd.
o Exhibit 157: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 158: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 159: Sun Pharmaceutical Industries Ltd. - Key offerings
o 12.16 Theseus Pharmaceuticals.
o Exhibit 160: Theseus Pharmaceuticals. - Overview
o Exhibit 161: Theseus Pharmaceuticals. - Product / Service
o Exhibit 162: Theseus Pharmaceuticals. - Key offerings
o 12.17 Xencor Inc.
o Exhibit 163: Xencor Inc. - Overview
o Exhibit 164: Xencor Inc. - Product / Service
o Exhibit 165: Xencor Inc. - Key news
o Exhibit 166: Xencor Inc. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 167: Inclusions checklist
o Exhibit 168: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 169: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 170: Research methodology
o Exhibit 171: Validation techniques employed for market sizing
o Exhibit 172: Information sources
o 13.5 List of abbreviations
o Exhibit 173: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global gastrointestinal stromal tumors therapeutics market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Distribution Channel ($ billion)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits48: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits49: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Route of Administration
Exhibits51: Data Table on Comparison by Route of Administration
Exhibits52: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Parenteral - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Parenteral - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Route of Administration ($ billion)
Exhibits61: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ billion)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AB Science SA - Overview
Exhibits112: AB Science SA - Product / Service
Exhibits113: AB Science SA - Key offerings
Exhibits114: AROG Pharmaceuticals INC. - Overview
Exhibits115: AROG Pharmaceuticals INC. - Product / Service
Exhibits116: AROG Pharmaceuticals INC. - Key offerings
Exhibits117: Ascentage Pharma - Overview
Exhibits118: Ascentage Pharma - Product / Service
Exhibits119: Ascentage Pharma - Key offerings
Exhibits120: Bayer AG - Overview
Exhibits121: Bayer AG - Business segments
Exhibits122: Bayer AG - Key news
Exhibits123: Bayer AG - Key offerings
Exhibits124: Bayer AG - Segment focus
Exhibits125: Blueprint Medicines Corp. - Overview
Exhibits126: Blueprint Medicines Corp. - Product / Service
Exhibits127: Blueprint Medicines Corp. - Key news
Exhibits128: Blueprint Medicines Corp. - Key offerings
Exhibits129: Bristol Myers Squibb Co. - Overview
Exhibits130: Bristol Myers Squibb Co. - Product / Service
Exhibits131: Bristol Myers Squibb Co. - Key news
Exhibits132: Bristol Myers Squibb Co. - Key offerings
Exhibits133: Daiichi Sankyo Co. Ltd. - Overview
Exhibits134: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits135: Daiichi Sankyo Co. Ltd. - Key news
Exhibits136: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits137: Deciphera Pharmaceuticals Inc - Overview
Exhibits138: Deciphera Pharmaceuticals Inc - Business segments
Exhibits139: Deciphera Pharmaceuticals Inc - Key news
Exhibits140: Deciphera Pharmaceuticals Inc - Key offerings
Exhibits141: Deciphera Pharmaceuticals Inc - Segment focus
Exhibits142: Ipsen Pharma - Overview
Exhibits143: Ipsen Pharma - Business segments
Exhibits144: Ipsen Pharma - Key offerings
Exhibits145: Ipsen Pharma - Segment focus
Exhibits146: Mendus AB - Overview
Exhibits147: Mendus AB - Product / Service
Exhibits148: Mendus AB - Key offerings
Exhibits149: Novartis AG - Overview
Exhibits150: Novartis AG - Business segments
Exhibits151: Novartis AG - Key offerings
Exhibits152: Novartis AG - Segment focus
Exhibits153: Pfizer Inc. - Overview
Exhibits154: Pfizer Inc. - Product / Service
Exhibits155: Pfizer Inc. - Key news
Exhibits156: Pfizer Inc. - Key offerings
Exhibits157: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits158: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits159: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits160: Theseus Pharmaceuticals. - Overview
Exhibits161: Theseus Pharmaceuticals. - Product / Service
Exhibits162: Theseus Pharmaceuticals. - Key offerings
Exhibits163: Xencor Inc. - Overview
Exhibits164: Xencor Inc. - Product / Service
Exhibits165: Xencor Inc. - Key news
Exhibits166: Xencor Inc. - Key offerings
Exhibits167: Inclusions checklist
Exhibits168: Exclusions checklist
Exhibits169: Currency conversion rates for US$
Exhibits170: Research methodology
Exhibits171: Validation techniques employed for market sizing
Exhibits172: Information sources
Exhibits173: List of abbreviations